|Videos|March 25, 2022
Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids
Author(s)Miranda Hester
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Nonsteroidal topical therapies expand treatment options for pediatric skin conditions
2
Eczema, delayed allergen introduction, and early antibiotics top list of childhood food allergy risk factors
3
What Pediatricians Should Know About JAK Inhibitors Before Referral
4
Trump signs executive order overhauling childhood vaccine recommendations
5